The Relationship between Cardiac Magnetic Resonance-Assessed Replacement and Interstitial Fibrosis and Ventricular Arrhythmias in Hypertrophic Cardiomyopathy

被引:7
|
作者
Karabinowska-Malocha, Aleksandra [1 ]
Dziewiecka, Ewa [1 ]
Banys, Pawel [2 ]
Urbanczyk-Zawadzka, Malgorzata [2 ]
Krupinski, Maciej [2 ]
Mielnik, Malgorzata [2 ]
Lach, Jacek [1 ]
Budkiewicz, Aleksandra [3 ]
Podolec, Piotr [1 ]
Zydzik, Lukasz [3 ]
Wisniowska-Smialek, Sylwia [1 ]
Holcman, Katarzyna [1 ]
Kostkiewicz, Magdalena [1 ]
Rubis, Pawel [1 ]
机构
[1] Jagiellonian Univ, John Paul II Hosp, Dept Cardiac & Vasc Dis, Coll Med, Pradnicka St 80, PL-31202 Krakow, Poland
[2] John Paul 2 Hosp, Dept Radiol, Pradnicka St 80, PL-31202 Krakow, Poland
[3] Jagiellonian Univ, John Paul II Hosp, Dept Cardiac & Vasc Dis, Students Sci Grp Heart Failure,Med Coll, Pradnicka St 80, PL-31202 Krakow, Poland
来源
JOURNAL OF PERSONALIZED MEDICINE | 2022年 / 12卷 / 02期
关键词
hypertrophic cardiomyopathy; LGE; myocardial fibrosis; ECV; LATE GADOLINIUM ENHANCEMENT; EXTRACELLULAR VOLUME; MYOCARDIAL FIBROSIS; PROGNOSTIC VALUE; DELAYED ENHANCEMENT; SUDDEN-DEATH; RISK; ASSOCIATION; MANAGEMENT; DIAGNOSIS;
D O I
10.3390/jpm12020294
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Non-sustained ventricular tachycardia (nsVT) creates the electrical basis for sudden cardiac death (SCD) in hypertrophic cardiomyopathy (HCM). We aimed to evaluate the relationship between interstitial fibrosis on cardiac magnetic resonance (CMR) and nsVT in HCM. A total of 50 HCM patients underwent CMR with a 3 T scanner to determine the presence of replacement fibrosis expressed by late gadolinium enhancement (LGE), and interstitial fibrosis expressed by native T ₁, post-contrast T ₁, and extracellular volume (ECV). The incidence of nsVT was assessed by Holter monitoring. We detected nsVT in 14 (28%) out of 50 HCM patients. Replacement fibrosis expressed by LGE was present in 37 (74%) patients and only showed a trend towards a differentiation between the groups with and without nsVT (p = 0.07). However, the extent of LGE was clearly higher in the nsVT group (3.8 +/- 4.9% vs. 7.94 +/- 4.5%, p = 0.002) and was an independent predictor of nsVT in a multivariable regression analysis (OR 1.2; 95%CI 1.02-1.4; p = 0.02). No relationship was observed between interstitial fibrosis and nsVT. To conclude, it was found that it is not the mere presence but the actual extent of LGE that determines the occurrence of nsVT in HCM patients; the role of interstitial fibrosis remains unclear.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Complementary Role of Echocardiography and Cardiac Magnetic Resonance in Hypertrophic Cardiomyopathy
    Hindieh, Waseem
    Chan, Raymond
    Rakowski, Harry
    CURRENT CARDIOLOGY REPORTS, 2017, 19 (09)
  • [22] Association of Late Gadolinium Enhancement and Degree of Left Ventricular Hypertrophy Assessed on Cardiac Magnetic Resonance Imaging With Ventricular Tachycardia in Children With Hypertrophic Cardiomyopathy
    Spinner, Joseph A.
    Noel, Cory V.
    Denfield, Susan W.
    Krishnamurthy, Rajesh
    Jeewa, Aamir
    Dreyer, William J.
    Maskatia, Shiraz A.
    AMERICAN JOURNAL OF CARDIOLOGY, 2016, 117 (08) : 1342 - 1348
  • [23] The relationship between serum Lumican levels and myocardial fibrosis in patients with hypertrophic cardiomyopathy
    Hancioglu, Emirhan
    Ozcan, Sevgi
    Donmez, Esra
    Terzioglu, Cemal
    Kirankaya, Ayseguel
    Tenekecigil, Aslihan
    Okuyan, Ertugrul
    Sahin, Irfan
    BIOMARKERS IN MEDICINE, 2025, 19 (06) : 187 - 195
  • [24] Efficacy of Novel Noncontrast Cardiac Magnetic Resonance Methods in Indicating Fibrosis in Hypertrophic Cardiomyopathy
    Sharifian, Maedeh
    Rezaeian, Nahid
    Asadian, Sanaz
    Mohammadzadeh, Ali
    Nahardani, Ali
    Kasani, Kianosh
    Toloueitabar, Yaser
    Farahmand, Ali Mohammad
    Hosseini, Leila
    CARDIOLOGY RESEARCH AND PRACTICE, 2021, 2021
  • [25] Myocardial fibrosis detected by cardiac CT predicts ventricular fibrillation/ventricular tachycardia events in patients with hypertrophic cardiomyopathy
    Shiozaki, Afonso Akio
    Senra, Tiago
    Arteaga, Edmund
    Martinelli Filho, Martino
    Pita, Cristiane Guedes
    Avila, Luis Francisco R.
    Parga Filho, Jose Rodrigues
    Mady, Charles
    Kalil-Filho, Roberto
    Bluemke, David A.
    Rochitte, Carlos Eduardo
    JOURNAL OF CARDIOVASCULAR COMPUTED TOMOGRAPHY, 2013, 7 (03) : 173 - 181
  • [26] Prognostic Value of Late Gadolinium Enhancement on Cardiac Magnetic Resonance Imaging in Japanese Hypertrophic Cardiomyopathy Patients
    Hen, Yasuki
    Iguchi, Nobuo
    Utanohara, Yuko
    Takada, Kaori
    Machida, Haruhiko
    Takayama, Morimasa
    Sumiyoshi, Tetsuya
    CIRCULATION JOURNAL, 2014, 78 (04) : 929 - 937
  • [27] Myocardial fibrosis progression on cardiac magnetic resonance in hypertrophic cardiomyopathy
    Choi, Hong-Mi
    Kim, Kyung-Hee
    Lee, Joo Myung
    Yoon, Yeonyee E.
    Lee, Seung-Pyo
    Park, Eun-Ah
    Lee, Whal
    Kim, Yong-Jin
    Cho, Goo-Yeong
    Sohn, Dae-Won
    Kim, Hyung-Kwan
    HEART, 2015, 101 (11) : 870 - 876
  • [28] Predictive value of cardiac magnetic resonance mechanical parameters for myocardial fibrosis in hypertrophic cardiomyopathy with preserved left ventricular ejection fraction
    Hou, Xian
    Xiong, Xing
    Li, Xia
    Bi, Jianhua
    Xu, Gaofeng
    Wang, Yining
    Jiang, Shu
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [29] Role of cardiac magnetic resonance imaging in predicting atrial fibrillation in patients with hypertrophic cardiomyopathy
    Guler, Arda
    Sahin, Ahmet Anil
    Ucar, Servet Umut
    Aydin, Sinem
    Uygur, Begum
    Celik, Omer
    Erturk, Mehmet
    CUKUROVA MEDICAL JOURNAL, 2022, 47 (02): : 811 - 819
  • [30] Endogenous contrast T1rho cardiac magnetic resonance for myocardial fibrosis in hypertrophic cardiomyopathy patients
    Wang, Chunhua
    Zheng, Jie
    Sun, Jiayu
    Wang, Yuqing
    Xia, Rui
    Yin, Qian
    Chen, Wei
    Xu, Zigian
    Liao, Jichun
    Zhang, Bing
    Gao, Fabao
    JOURNAL OF CARDIOLOGY, 2015, 66 (5-6) : 520 - 526